Inmune Bio, Inc. (19) | Business Operations (3)
- Sales Agreements (3)
- At-The-Market Sales Agreement, dated March 10, 2021, between the Company and BTIG (Filed With SEC on March 11, 2021)
- Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on August 19, 2020)
- At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)
